Schizophrenia is a chronic psychiatric disorder frequently characterized by significant disturbances in behavior, hallucinations (e.g., seeing or hearing things that aren’t really there}, delusions (false beliefs), disorders of thought (unusual or dysfunctional ways of thinking), and disturbances in normal emotions and reduced feelings of pleasure in everyday life.
While there are many medications approved for the treatment of schizophrenia, the drugs frequently do not completely eradicate all the signs and symptoms of the disease. Compliance is another significant factor complicating the successful treatment of schizophrenia. For example, many people taking antipsychotic medications stop taking their medication because the medications also affect their metabolism resulting in weight gain. As a result, medical science continues to aggressively explore new and more effective drugs that can provide relief to those people who suffer from this disorder and with fewer unwanted side effects.
SPRI is currently conducting a clinical trial to evaluate a new approach to the research studies & treatment of schizophrenia that may have the added benefit of a reduced risk of weight gain.
At a minimum, in order to be eligible to participate, you must be someone who
➢ Is at lest 18 years of age, and
➢ Has a medical diagnosis of schizophrenia.
➢ Note: Additional entry criteria apply
Participation is strictly confidential. Study medication, and study-related visits, procedures and tests are offered free of charge. We also offer limited financial compensation, as well as reimbursement to cover reasonable food and travel-related expenses.
If you would like to volunteer or learn more about what is involved in participating in such a clinical trial or wish to see if you qualify to participate, please call 718-616-2400 or click the Contact US button below to send us an email.